272 10-YEAR FOLLOW-UP OF A RANDOMISED CONTROLLED TRIAL COMPARING NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE FOR OESOPHAGEAL CANCER (CROSS)
Ben M. Eyck(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC), Berend J. van der Wilk(Erasmus MC Cancer Institute), Maurice J.C. van der Sangen(Radboud University Nijmegen), Geke A.P. Hospers(University Medical Center Groningen), Jannet C. Beukema(University Medical Center Groningen), Tom Rozema(Radboud University Nijmegen), Daan Nieboer(Erasmus MC), R.J.B. Blaisse(Rijnstate Hospital), Joël Shapiro(The Netherlands Cancer Institute), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Herman van Dekken(Erasmus MC), M Berge Henegouwen(Amsterdam University Medical Centers), Paul Hagen(Erasmus MC), Miguel A. Cuesta(Hospital General Universitario de Albacete), J Plukker(University Medical Center Groningen), Janny G. Reinders(Dutch Art Institute), JJB van Lanschot(Erasmus MC), O.R. Busch(Amsterdam University Medical Centers), Maarten C.C.M. Hulshof(Academic Medical Center), Hans A. Verheul(Amsterdam University Medical Centers), EJ Spillenaar Bilgen(Rijnstate Hospital), A Piet(Amsterdam University Medical Centers), Bas P. L. Wijnhoven(Inserm), G-J. Creemers(Radboud University Nijmegen), F. J. W. Ten Kate(Erasmus MC), C.J.A. Punt(Amsterdam University Medical Centers), CM van Rij(Erasmus MC), J.J. Bonenkamp(Radboud University Nijmegen), H.W. Tilanus(Erasmus MC), Katharina Biermann(Erasmus University Rotterdam)
Cited by 0
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
A calibration hierarchy for risk models was defined: from utopia to empirical data
|Journal of Clinical Epidemiology|2016|834
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788